Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Genetic Signatures Ltd

GSS.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Advanced Medical Equipment & Technology ·

Australia Micro Cap Analyst: BUY

Last Close

$0.04

▲ +1.72%

Market Cap $9.45M · Vol 358.81K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$9.45M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

+24.10%

YoY

RSI (14)

47.62

Momentum

Beta

0.69

vs Market

52W High

$0.30

85.02% below

52W Low

$0.04

17.06% above

Volume

358.81K

Avg 192.24K

P/B

1.66

Price-to-book

ROE

-36.16%

Return on equity

Free Float

83.13%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Genetic Signatures Ltd (GSS.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GSS.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.72%

-6.35%

-26.25%

-54.62%

YTD

-76.40%

-81.27%

-88.27%

-95.56%

Financials & Valuation

TTM · Annual

Total Revenue	$14.06M
Net Income	$-13,228,404.00
Revenue Growth (YoY)	+19.38%
Gross Margin	45.46%
Operating Margin	-60.37%
Net Profit Margin	-94.10%
ROE	-36.16%
ROA · ROIC	-32.98% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.87
P/B	1.66
P/FCF	N/A
EPS Growth	+24.10%
Outstanding Shares	227.14M

Technical Indicators

50-Day SMA	$0.04
200-Day SMA	$0.10
RSI (14)	47.62
Beta	0.69
52-Week High	$0.30
52-Week Low	$0.04

Volume Today	358.81K
Avg Daily Volume (30D)	192.24K
Relative Volume	1.87x
Volatility (10D)	64.40
Volatility (30D)	62.47
Free Float	83.13%

Analyst Consensus

BUY

Current Price $0.04

Mean Target N/A

52W Low$0.04 52W High$0.30

Current

Target

$0.04 $0.30

Current Analyst target

· 1 analysts

Identifiers

ExchangeASX

FIGIBBG007J39FG7

ISINAU000000GSS4

CountryAustralia

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateAug 24, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others.